Ovid Therapeutics

doctor examining brain mri scans

Biotech

Ovid pauses ph. 2 plans for ROCK2 inhibitor to mull rival's data

Ovid is pumping the brakes on a planned phase 2 trial in a type of brain lesion while it considers any lessons from Recursion’s rival candidate.

James Waldron Nov 13, 2024 8:15am

An artists rendition of a seizure in the brain The brain is outlined in neon blue with the overactive neurons in glowing r

Ovid halts preclinical work, IV program after soticlestat fail

Aug 13, 2024 9:15am

long shot miss basketball hoop fail shoot

Takeda flunks pivotal epilepsy tests but mulls path to market

Jun 17, 2024 8:50am

cash runway cash airplane extend deal earnings

Ovid sells some royalty rights to Takeda-partnered seizure drug

Oct 18, 2023 8:00am

Rocky Path

Ovid snaps up Rock2 inhibitor from Sam Waksal-led Graviton

May 1, 2023 11:06am

chutes ladders chutes AND ladders

Former Roche pharma head to be new Bayer CEO—Chutes & Ladders

Feb 10, 2023 9:30am